Track the Senores Pharmaceuticals Limited stock price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Senores Pharmaceuticals Limited has logged 86 reports. Market capitalisation: €61.1bn. The latest transaction was filed on 1 April 2026 (Purchase). Among the most active insiders: Sanjay Shaileshbhai Majmudar. Every trade is free.
86
Insider Decl.
n/a
Thresholds
€9m
80 ops.
Buy Volume
€119,035
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Senores Pharmaceuticals Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹1,620.00.
28Σ signal
Buys €9m€119,035 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,430 of 29,062 companies
50.3
score / 100
Value
28
Quality
73
FCF yld-3.3%
Earn yld1.9%
EV/EBITDA29.9x
ROE14%
Gross mgn60%
Net mgn18%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
300 shares@ ₹654.0333100.0% of flowEquity SharesSEBI:ef17a27ecfd83ab685e0a17f4de184bdf4581b6e
25 of 86 declarations
Acerca de Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la XBOM. Se enfoca en el desarrollo y comercialización de productos farmacéuticos innovadores.